EQS-Adhoc

​​​​​​​Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski

EQS-Ad-hoc: Epigenomics AG / Key word(s): Personnel ​​​​​​​Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski 27-Jan-2023 / 14:16 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski

Berlin, January 27, 2023 - The Chairman of the Supervisory Board of Epigenomics AG, Heino von Prondzynski, informed the Boards today that he will resign from his mandate effective March 31, 2023, for health reasons and will leave the Supervisory Board at that time. Mr. von Prondzynski has been Chairman of the Supervisory Board of Epigenomics AG since May 2012. The Supervisory Board will appoint a successor from among its members at short notice.

 

Contact:
Company
Epigenomics AG, Geneststraße 5, 10829 Berlin
Tel [phone], Fax [phone], Email: [e-mail]

Investor Relations
IR.on AG, Frederic Hilke, Tel [phone], Email: [e-mail]

 

Note on forward-looking statements

This publication expressly or implicitly contains forward-looking statements concerning Epigenomics AG and its business. These statements involve certain known and unknown risks, uncertainties and other factors that may cause Epigenomics AG’s actual results, financial condition and performance to be materially different from any future results, performance or achievements expressed or implied by such statements. Epigenomics makes this announcement as of the date of this release and does not intend to update any forward-looking statements contained herein as a result of new information or future events or otherwise.

 

---

27-Jan-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.epigenomics.com
ISIN:	DE000A32VN83
WKN:	A32VN8
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	1545583

End of Announcement	EQS News Service

1545583  27-Jan-2023 CET/CEST